<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Nimverta</title><link>https://nimverta.com/</link><description>Recent content on Nimverta</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Sun, 17 Aug 2025 12:00:00 +0200</lastBuildDate><atom:link href="https://nimverta.com/index.xml" rel="self" type="application/rss+xml"/><item><title>Prof. Serge Ferrari</title><link>https://nimverta.com/advisory/prof_serge_ferrari/</link><pubDate>Sun, 17 Aug 2025 12:00:00 +0200</pubDate><guid>https://nimverta.com/advisory/prof_serge_ferrari/</guid><description>Key Opinion Leader (KOL) in osteoporosis and metabolic bone diseases, Prof. Serge Ferrari is a renowned clinical researcher at the University of Geneva, Switzerland.</description></item><item><title>Dr. Esther Wehrle</title><link>https://nimverta.com/collaborators/dr-esther-wehrle/</link><pubDate>Fri, 01 Aug 2025 12:05:00 +0200</pubDate><guid>https://nimverta.com/collaborators/dr-esther-wehrle/</guid><description>[Text for Esther Wehrle.]</description></item><item><title>Dr. Amit Singh</title><link>https://nimverta.com/team/amit-singh/</link><pubDate>Fri, 01 Aug 2025 11:00:00 +0200</pubDate><guid>https://nimverta.com/team/amit-singh/</guid><description>Dr. Amit Singh is a bioinformatic data scientist. He holds a bachelor&amp;rsquo;s degree in Physics and a master&amp;rsquo;s degree in Biochemistry.</description></item><item><title>Prof. Alessandro Angelini</title><link>https://nimverta.com/advisory/prof_alessandro_angelini/</link><pubDate>Sun, 17 Aug 2025 12:00:00 +0200</pubDate><guid>https://nimverta.com/advisory/prof_alessandro_angelini/</guid><description>Expert in peptide design and formulation, Co-Founder and CSO at Arzanya, and researcher at the European Center for Living Technology, Ca’ Foscari University of Venice, Italy.</description></item><item><title>Dr. Sagar</title><link>https://nimverta.com/collaborators/dr-sagar/</link><pubDate>Fri, 01 Aug 2025 12:05:00 +0200</pubDate><guid>https://nimverta.com/collaborators/dr-sagar/</guid><description>[text for Sagar]</description></item><item><title>Rob Chisholm</title><link>https://nimverta.com/team/rob-chisholm/</link><pubDate>Fri, 01 Aug 2025 11:01:00 +0200</pubDate><guid>https://nimverta.com/team/rob-chisholm/</guid><description>Rob Chisholm is an accomplished biopharmaceutical executive with over 25 years of global industry experience, specializing in bringing innovative therapies to market for patients with serious medical conditions.</description></item><item><title>Prof. Iván Durán</title><link>https://nimverta.com/advisory/prof_ivan_duran/</link><pubDate>Sun, 17 Aug 2025 12:00:00 +0200</pubDate><guid>https://nimverta.com/advisory/prof_ivan_duran/</guid><description>Expert on rare bone disease and creating research animal models for studying rare bone disease. University of Malaga, Spain.</description></item><item><title>Prof. Anjali Kusumbe</title><link>https://nimverta.com/team/anjali-kusumbe/</link><pubDate>Fri, 01 Aug 2025 11:02:00 +0200</pubDate><guid>https://nimverta.com/team/anjali-kusumbe/</guid><description>Prof. Anjali Kusumbe is a vascular biologist and expert in bone vasculature, ageing, and tissue regeneration.</description></item><item><title>Dr. Gwang Jin Kim</title><link>https://nimverta.com/team/gwang-jin-kim/</link><pubDate>Fri, 01 Aug 2025 11:03:00 +0200</pubDate><guid>https://nimverta.com/team/gwang-jin-kim/</guid><description>Dr. Gwang Jin Kim is a specialist in search engine optimization and digital strategy, ensuring that Nimverta&amp;rsquo;s scientific mission and message reach a global audience.</description></item><item><title>Prof. Lothar Seefried</title><link>https://nimverta.com/advisory/prof_lothar_seefried/</link><pubDate>Sun, 17 Aug 2025 12:00:00 +0200</pubDate><guid>https://nimverta.com/advisory/prof_lothar_seefried/</guid><description>Leading clinician and researcher in the field of rare bone diseases, metabolic bone disorders, and orthopedic surgery and key opinion leader.</description></item><item><title>Prof. Shubhendu Palei</title><link>https://nimverta.com/advisory/prof_shubhendu_palei/</link><pubDate>Sun, 17 Aug 2025 12:00:00 +0200</pubDate><guid>https://nimverta.com/advisory/prof_shubhendu_palei/</guid><description>Expert in chemical biology and synthetic biology, with a focus on the design and development of bioactive molecules, peptide therapeutics, and chemical probes for biomedical applications.</description></item><item><title>Nimverta Secures Venture Kick Support to Advance Bone Regeneration Therapy</title><link>https://nimverta.com/blog/simple-blog-post-1/</link><pubDate>Tue, 24 Jun 2025 09:00:00 +0200</pubDate><guid>https://nimverta.com/blog/simple-blog-post-1/</guid><description>Nimverta, a Zurich-based biotech startup, has secured CHF 10,000 in funding from Venture Kick, entering a new phase in its journey to develop first-in-class peptide therapies for bone regeneration.</description></item><item><title>John Doe</title><link>https://nimverta.com/author/john-doe/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://nimverta.com/author/john-doe/</guid><description>Lorem ipsum dolor sit amet, consectetur adipiscing elit. Proin sit amet vulputate augue. Duis auctor lacus id vehicula gravida.</description></item><item><title>Mark Dinn</title><link>https://nimverta.com/author/mark-dinn/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://nimverta.com/author/mark-dinn/</guid><description>Lorem ipsum dolor sit amet, consectetur adipiscing elit. Proin sit amet vulputate augue. Duis auctor lacus id vehicula gravida.</description></item></channel></rss>